Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.36 (
hyaluronidase
)
4,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Subcellular distribution of
hyaluronidase
of rat liver was studied during spontaneous restoration during the 1st, 2nd, 3rd days, and 1, 2, 3, 4 weeks of acute and chronic CCl4-hepatitis. Redistribution of relative specific activity of
hyaluronidase
was seen in the fractions of heavy and light mitochondria, microsomes and supernatant fraction, after an acute hepatic injury. Four weeks after the injury subcellular distribution was not yet normal. In
chronic hepatitis
the relative specific
hyaluronidase
activity was almost identical in the five subcellular fractions. In the course of restoration the relative specific activity was increased in the fractions of heavy and light mitochondria and microsomes, but decreased in the nuclear and supernatant fractions.
...
PMID:[Intracellular distribution of hyaluronidase in rats with acute and chronic hepatitis and reparative liver regeneration]. 95 71
Following major tissue injury, hyaluronic acid production increases as a rapid response survival mechanism. Increased hyaluronic acid production and turnover are often associated with increased
hyaluronidase
activity, the enzyme that degrades hyaluronic acid. We investigated whether hyaluronic acid and
hyaluronidase
can be used as non-invasive markers of acute disease activity in hepatitis C by studying 26 patients with acute hepatitis C, 89 with
chronic hepatitis
C and 32 healthy controls. Chronic hepatitis C subjects were classified into five subgroups according to the stage of liver fibrosis. Serum aspartate aminotransferase and alanine aminotransferase activities and hyaluronic acid levels were increased in hepatitis C patients compared with the controls. Serum hyaluronic acid elevation correlated with disease progression. Serum
hyaluronidase
activities were also increased in patients compared with the controls, but decreased with disease progression. We conclude that both
hyaluronidase
and hyaluronic acid may be useful as early non-invasive serum indicators of disease activity in acute hepatitis C.
...
PMID:Evaluation of serum hyaluronic acid level and hyaluronidase activity in acute and chronic hepatitis C. 1759 63